共 50 条
- [1] Agreement of amyloid PET and CSF biomarkers for Alzheimer's disease on Lumipulse [J]. ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2019, 6 (09): : 1815 - 1824
- [3] Clinical validation of the Lumipulse G cerebrospinal fluid assays for routine diagnosis of Alzheimer’s disease [J]. Alzheimer's Research & Therapy, 11
- [4] Advantages and disadvantages of the use of the CSF Amyloid β (Aβ) 42/40 ratio in the diagnosis of Alzheimer’s Disease [J]. Alzheimer's Research & Therapy, 11
- [10] Exploring the potential of fully automated LUMIPULSE G plasma assays for detecting Alzheimer’s disease pathology [J]. Alzheimer's Research & Therapy, 16